FEops receives CE mark for its TAVIguideTM simulation software

Ghent, Belgium: 24 September 2015 - FEops has received the CE mark for its transcatheter aortic valve implantation (TAVI) simulation software. The TAVIguide technology is designed to revolutionise preoperative planning for TAVI by providing insights into the interaction between a patient's native aortic root and the aortic valve. The company reports that clinical evidence shows that implementation of the software enables optimisation of the treatment planning by carefully evaluating the impact of device size and position prior to the intervention, in a patient-specific manner.

More information on the press release or on FEops' website.


Next > Data Safety Monitoring Board recommends continuation of Nexstim Plc’s Phase III Stroke Therapy Trial

Previous > FRX Polymers US Environmental Protection Agency Award Winning Nofia® Flame Retardant Now Available for Worldwide Distribution